AT-03

N/A

Report date: 2025/11/27 20:00:08

Base Information

Drug NameAT-03
Drug Alias NameAT-03
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionPhagocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsAmyloidosisImmunoglobulin Light-chain Amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAttralus Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttralus Inc
Inactive CompaniesN/A
Active IndicationsAmyloidosisImmunoglobulin Light-chain Amyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A